Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation, known as Amwell (NYSE: AMWL), regularly issues news and updates about its role in digital care and technology-enabled healthcare. Company announcements highlight its SaaS-based care platform, relationships with payers, health systems and government organizations, and its ongoing work to support digital and hybrid care models.
On this news page, readers can follow Amwell’s earnings announcements and quarterly operating updates, which are often accompanied by investor conference calls and webcasts. The company frequently reports the timing of its financial results, provides access details for live audio webcasts and notes the availability of replay links through its investor resources.
Amwell’s news flow also covers commercial partnerships and contracts. For example, the company has reported on its role in the U.S. Defense Health Agency’s Digital First Program for the Military Health System, where its technology-enabled care platform powers virtual visits integrated with the MHS GENESIS electronic health record. News items describe how the platform supports military care teams, service members and their families across the global Department of Defense enterprise.
Investors and observers can also see updates on Amwell’s agreements with Elevance Health related to the LiveHealth Online white‑label digital care platform, as well as disclosures about equity inducement grants to new employees under its inducement plan. Together, these items provide insight into Amwell’s operational priorities, customer relationships and use of technology to support digital care programs.
For anyone tracking AMWL, this news feed brings together company-issued releases on financial results, major contracts, investor conference participation and corporate actions, offering a centralized view of Amwell’s public communications about its technology-enabled care business.
Summary not available.
Summary not available.
Summary not available.
Amwell (NYSE: AMWL) will report its first-quarter 2023 operating results on May 3, 2023, at 5 p.m. Eastern time. Following the earnings release, the management team will host a live conference call to discuss results and provide updates.
Investors can access the live audio webcast on the Amwell Investors website or dial in at (888) 510-2008 for U.S. listeners and (646) 960-0306 internationally. The conference ID is 7830032, with a replay available for 90 days post-call.
Amwell is a leader in digital healthcare, with a platform used by over 2,000 hospitals and covering over 80 million lives. The company aims to enhance healthcare access and quality through digital solutions, supporting various care types.
DarioHealth Corp. (Nasdaq: DRIO) has entered into a strategic partnership with Amwell (NYSE: AMWL), integrating Dario's cardiometabolic solutions into Amwell's digital care delivery platform, which covers over 90 million lives. This collaboration aims to enhance the care experience for individuals with conditions such as diabetes and hypertension by providing access to Dario's personalized digital health solutions. The Dario cardiometabolic suite will be available to Amwell customers in the second half of 2023, promoting a seamless member journey and supporting better health management.
Amwell (NYSE: AMWL) has announced the launch of its new cardiometabolic program, enhancing its ecosystem of digital health solutions to better serve members with chronic diseases like diabetes and high blood pressure. This initiative, in partnership with DarioHealth (Nasdaq: DRIO), integrates Dario's personalized digital therapeutic solutions into the Amwell platform, facilitating seamless referrals for clinicians. The program aims to improve health outcomes by ensuring continuous care and engagement for over one-third of Americans living with metabolic conditions. Through connected devices and coaching, members experience a holistic approach to managing their health.
Amwell (NYSE: AMWL) reported its Q4 and full-year 2022 financial results, revealing a total revenue of $79.2 million for Q4, up 9% year-over-year. Subscription revenue reached $30.7 million, and AMG Visit revenue was $35.1 million, contributing to a gross margin of 42.4%. Although the net loss narrowed to $61.6 million from the previous quarter's $70.6 million, adjusted EBITDA remained negative at ($43.4) million. Active providers surged 11% to approximately 107,000, with total visits increasing to 1.7 million, up 10%. The company projects revenue between $275 and $285 million for 2023, reflecting ongoing growth.
Amwell (NYSE: AMWL), a leader in digital healthcare, announces CFO Robert Shepardson will participate in a fireside chat at the Cowen 43rd Annual Healthcare Conference on March 7, 2023, at 9:10 AM ET. A follow-up audio webcast will be available afterward on their investor relations page. Amwell aims to enhance digital care delivery, connecting providers, insurers, patients, and innovators to improve access to quality care. The company supports over 2,000 hospitals and 55 health plan partners, covering over 80 million lives with its comprehensive digital health solutions.
Amwell (NYSE: AMWL), a digital healthcare leader, announced it will report its fourth quarter operating results for the period ending December 31, 2022, on February 22, 2023, at 5:00 p.m. Eastern Time. Following the earnings release, the management team will host a live conference call and webcast to discuss results and provide business updates. Access to the webcast will be available on the company's investor relations website. Amwell connects healthcare providers, insurers, and patients, serving over 80 million lives through its digital care platform.
Amwell® (NYSE: AMWL) announced its third-quarter financial results for 2022, reporting a total revenue of $69.2 million, an 11% increase from $62.2 million in Q3 2021. Subscription revenue grew by 19% to $31.9 million, while AMG Visit revenue was $28.8 million. Gross margin stood at 40%. The net loss was ($70.6 million), slightly higher than the ($69.7 million) loss in Q2 2022. Active providers increased by 23% to 98,500. The company expects to meet its annual revenue guidance of $275 to $285 million and has refined its Adjusted EBITDA outlook to between ($180) million and ($190) million.
FAQ
What is the current stock price of American Well (AMWL)?
What is the market cap of American Well (AMWL)?
